As a potential tumor suppressor of lung cancer, selective targeting of Bit1 in lung tumors may serve as a therapeutic strategy to reactivate the apoptotic mechanism in lung cancer cells and block tumor progression. The gene discussed is PTRH2; the disease is lung carcinoma.